These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27080620)

  • 21. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: a multicentre, prospective cohort study.
    STARSurg Collaborative
    Anaesthesia; 2018 Oct; 73(10):1214-1222. PubMed ID: 29984818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
    Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
    Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.
    Caldeira D; Alarcão J; Vaz-Carneiro A; Costa J
    BMJ; 2012 Jul; 345():e4260. PubMed ID: 22786934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.
    Gayat E; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Chousterman BG; Lu Q; Laterre PF; Monnet X; Darmon M; Leone M; Guidet B; Sonneville R; Lefrant JY; Fournier MC; Resche-Rigon M; Mebazaa A; Legrand M;
    Intensive Care Med; 2018 May; 44(5):598-605. PubMed ID: 29766216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
    Peng F; Su J; Lin J; Niu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study.
    Roberts DJ; Smith SA; Tan Z; Dixon E; Datta I; Devrome A; Hemmelgarn BR; Tonelli M; Pannu N; James MT
    J Surg Res; 2021 Jul; 263():34-43. PubMed ID: 33631376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE inhibitors and ARBs: Managing potassium and renal function.
    Momoniat T; Ilyas D; Bhandari S
    Cleve Clin J Med; 2019 Sep; 86(9):601-607. PubMed ID: 31498767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Fröhlich H; Nelges C; Täger T; Schwenger V; Cebola R; Schnorbach J; Goode KM; Kazmi S; Katus HA; Cleland JG; Clark AL; Frankenstein L
    Am Heart J; 2016 Aug; 178():28-36. PubMed ID: 27502849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of anemia in patients with type II diabetes and mild to moderate chronic kidney disease and the impact of anti-RAS medications.
    Dousdampanis P; Trigka K; Fourtounas C
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):552-7. PubMed ID: 24821151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of acute kidney injury developing outside the hospital in elderly.
    Turgutalp K; Bardak S; Horoz M; Helvacı I; Demir S; Kiykim AA
    Int Urol Nephrol; 2017 Jan; 49(1):113-121. PubMed ID: 27704319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review and Meta-Analysis.
    Chan CK; Huang YS; Liao HW; Tsai IJ; Sun CY; Pan HC; Chueh JS; Wang JT; Wu VC; Chu TS;
    Hypertension; 2020 Nov; 76(5):1563-1571. PubMed ID: 32869673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers increases the risk of postoperative acute kidney injury after elective endovascular abdominal aortic aneurysm repair.
    Xiang Y; Liu Y; Zhao J; Huang B; Wu Z; Chen X
    Chin Med J (Engl); 2022 Dec; 135(23):2836-2842. PubMed ID: 36728509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute kidney injury after cardiac surgery in infants and children: evaluation of the role of angiotensin-converting enzyme inhibitors.
    Phelps CM; Eshelman J; Cruz ED; Pan Z; Kaufman J
    Pediatr Cardiol; 2012 Jan; 33(1):1-7. PubMed ID: 21800174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization.
    Alabdan N; Gosmanova EO; Tran NQ; Oliphant CS; Pan H; Broyles JE; Hudson JQ
    Am J Med Sci; 2017 Feb; 353(2):172-177. PubMed ID: 28183419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis.
    Whiting P; Morden A; Tomlinson LA; Caskey F; Blakeman T; Tomson C; Stone T; Richards A; Savović J; Horwood J
    BMJ Open; 2017 Apr; 7(4):e012674. PubMed ID: 28389482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.